Cardiovascular Medicine
State of the Heart 2022
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Agenda
  • Program Materials
  • Funding Support
Image

Featuring: Drs Darren McGuire, David Cherney, Tara Sedlak, Marc S. Sabatine,
Credits: N/A
Details: Four presentations with clickable links for easy navigation to the content of interest to you.
View Session 1

Image

Featuring: Drs Megha Poddar, Jacques Genest, Milan Gupta, Deepak Bhatt
Credits: N/A
Details: Four presentations with clickable links for easy navigation to the content of interest to you.
View Session 2

Image

Featuring: Drs Paul Dorian, Nadia Giannetti, Milan Gupta, Deepak Bhatt
Credits: N/A
Details: Four presentations with clickable links for easy navigation to the content of interest to you.
View Session 3

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
The OnDemand version of this program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

 

Continue learning with MDRead

Published on March 31, 2022

I’m ready to use natriuretic peptide testing in my patients with dyspnea to diagnose heart failure...

How to incorporate BNP testing into primary care....

Published on May 06, 2022

Hypertension- A Salty Topic

Why are we still talking about hypertension?   &nbs...

Published on October 13, 2022

SOME CALL IT SLEEP

What’s New in Insomnia Management and Treatment &ld...

Image
Featuring: Drs Darren McGuire, David Cherney, Tara Sedlak, Marc S. Sabatine,
Credits: N/A
Details: Four presentations with clickable links for easy navigation to the content of interest to you.
View Session 1
Image
Featuring: Drs Megha Poddar, Jacques Genest, Milan Gupta, Deepak Bhatt
Credits: N/A
Details: Four presentations with clickable links for easy navigation to the content of interest to you.
View Session 2
Image
Featuring: Drs Paul Dorian, Nadia Giannetti, Milan Gupta, Deepak Bhatt
Credits: N/A
Details: Four presentations with clickable links for easy navigation to the content of interest to you.
View Session 3

Resources:
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.

Credits:
The OnDemand version of this program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

 

SESSION 1 - LEARNING OBJECTIVES

  • Explore current role of GLP-1 agonists in clinical practice
  • Recognize the impact of kidney protection for cardiac protection
  • Determine when to use medical vs surgical treatment in stable CAD
  • Describe appropriate antiplatelet therapy for stable CAD patients

SESSION 2 - LEARNING OBJECTIVES

  • Describe a guidelines centric approach to manage and support patients with obesity
  • Distinguish the appropriate use of ezetimibe or PCSK9 inhibitors in secondary prevention
  • Discuss the role of a new market entrance in lipid management
  • Apply guideline centric strategies for managing cardiovascular risk beyond LDL-C

SESSION 3 - LEARNING OBJECTIVES

  • Summarize the benefits and challenges with using DOAC’s
  • Describe appropriate management strategies and therapies for managing patients with HFrEF and HFpEF
  • Explore developments in cardiovascular medicine that may change how we treat patients in the future

The OnDemand recordings of this live program are NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

Program Chapter
Presenter
SESSION ONE
GLP-1 agonists: underused and underappreciated?
Darren McGuire
CKD: save the kidneys, save the heart
David Cherney
Stable CAD: when to use antianginals and when to revascularize
Tara Sedlak
Stable CAD: ASA alone, prolonged DAPT or low-dose rivaroxaban?
Marc S. Sabatine
SESSION TWO
Have we entered a new era in obesity management?
Megha Poddar
When to use ezetimibe or PCSK9 inhibitors in secondary prevention
Jacques Genest
Inclisiran: the new LDL kid on the block
Milan Gupta
Cardiovascular risk reduction: more than just LDL-C
Deepak Bhatt
SESSION THREE
Lessons learned after a decade of experience with DOAC’s
Paul Dorian
HFrEF: how to start and titrate the four pillars of treatment
Nadia Giannetti
HFpEF: which drugs have become standard of care?
Milan Gupta
CV medicine in the next decade: predicting the future
Deepak Bhatt

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program is available for CCRN members of the CCRN website. Visit www.ccrnmd.com/resources to download the materials.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from Gold: HLS Therapeutics; Silver: AstraZeneca, Bayer, BMS/Pfizer Alliance, Boehringer Ingelheim, Janssen, KYE Pharmaceuticals, Sanofi and in-kind support from Pfizer.

 

 

 

 

 

 

 

 

Continue learning with MDRead

Published on March 31, 2022

I’m ready to use natriuretic peptide testing in my patients with dyspnea to diagnose heart failure...

How to incorporate BNP testing into primary care....

Published on May 06, 2022

Hypertension- A Salty Topic

Why are we still talking about hypertension?   &nbs...

Published on October 13, 2022

SOME CALL IT SLEEP

What’s New in Insomnia Management and Treatment &ld...